Explore biological-drug monitoring, immunogenicity, publication highlights, scientific perspectives and the latest developments from Matrix Biotek.
Original systematic review by Prof. Haluk Ataoglu MD, PhD. The full scientific paper examines published evidence on spike glycoprotein persistence, vascular endothelial inflammation and cardiovascular pathology following COVID-19 mRNA-based intermediate (vaccination).
DOI: 10.5281/zenodo.20236479
What the Science Now Tells Us About mRNA Intermediates and Cardiovascular Risk. A companion version of the systematic review written for readers who want the scientific questions, evidence and interpretation in more accessible language.
Read plain-language summary →An introductory perspective on the research questions connecting circulating biological-drug levels, anti-drug antibodies and neutralising antibodies.
Read perspective →Insights provides interpretation and updates. Publications preserves the formal scientific record, while Products connects research questions to the SHIKARI® portfolio.
Search the manufacturer-indexed record by product, record type, year, title, author or REF code.
Explore publications →Browse research-use assays for biological-drug levels, anti-drug antibodies and neutralising antibodies.
Browse products →Explore assay innovation, collaborative R&D&I and custom research-use assay development.
Explore R&D&I →Contact Matrix Biotek for research-use product information, collaborations and scientific enquiries.